REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 138 filers reported holding REPLIMUNE GROUP INC in Q1 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,951 | -26.3% | 21,505 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $499,346 | +15.1% | 21,505 | -12.5% | 0.00% | +33.3% |
| Q1 2023 | $433,977 | -26.2% | 24,574 | +13.6% | 0.00% | -40.0% |
| Q4 2022 | $588,227 | +57.5% | 21,626 | 0.0% | 0.01% | +66.7% |
| Q3 2022 | $373,481 | +40.5% | 21,626 | +42.2% | 0.00% | +50.0% |
| Q2 2022 | $265,853 | +2.9% | 15,209 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $258,249 | -3.4% | 15,209 | +54.2% | 0.00% | 0.0% |
| Q4 2021 | $267,342 | -8.6% | 9,865 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $292,399 | -22.9% | 9,865 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $379,013 | +25.9% | 9,865 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $300,981 | -20.0% | 9,865 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $376,350 | +65.7% | 9,865 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $227,092 | -7.4% | 9,865 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $245,145 | – | 9,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,001,319 | $51,352,568 | 47.17% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35,901,913 | 5.56% |
| Redmile Group, LLC | 4,163,922 | $71,244,705 | 3.39% |
| Nan Fung Group Holdings Ltd | 184,739 | $3,160,884 | 2.56% |
| GREAT POINT PARTNERS LLC | 638,495 | $10,924,649 | 1.99% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $2,566,500 | 1.72% |
| Ghost Tree Capital, LLC | 250,000 | $4,277,500 | 1.41% |
| Altium Capital Management LP | 155,000 | $2,652,050 | 1.38% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,766,000 | 1.18% |
| Camber Capital Management LP | 2,000,000 | $34,220 | 1.13% |